The selective cholecystokininB receptor antagonist L-365,260 diminishes the expression of naloxone-induced morphine withdrawal symptoms in normal and neuropathic rats.

Source:http://linkedlifedata.com/resource/pubmed/id/9496717

Download in:

View as

General Info

PMID
9496717